beta-glycerophosphoric acid has been researched along with Cardiovascular Stroke in 4 studies
beta-glycerophosphoric acid: plays role in mineralization of bone in vitro
glycerol 2-phosphate : A glycerol monophosphate having the phosphate group at the 2-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Peng, L | 1 |
Li, M | 2 |
Zhao, K | 1 |
Ma, C | 1 |
Tang, H | 1 |
Li, Y | 1 |
Ke, X | 1 |
Wang, X | 2 |
Liang, J | 1 |
Wu, S | 1 |
Long, M | 1 |
Hu, C | 1 |
Ding, Y | 1 |
Zhao, AS | 1 |
Liu, T | 1 |
Wang, YN | 1 |
Gao, Y | 1 |
Li, JA | 1 |
Yang, P | 1 |
Roche, ET | 1 |
Hastings, CL | 1 |
Lewin, SA | 1 |
Shvartsman, D | 1 |
Brudno, Y | 1 |
Vasilyev, NV | 1 |
O'Brien, FJ | 1 |
Walsh, CJ | 1 |
Duffy, GP | 1 |
Mooney, DJ | 1 |
4 other studies available for beta-glycerophosphoric acid and Cardiovascular Stroke
Article | Year |
---|---|
Evaluation of an Injectable Hydrogel Based on Hyaluronic Acid-Chitosan/β-Glycerophosphate-Loaded Mesenchymal Stem Cells in Enhancing the Therapeutic Efficacy of Myocardial Infarction.
Topics: Animals; Chitosan; Glycerophosphates; Hyaluronic Acid; Hydrogels; Mesenchymal Stem Cells; Mice; Myoc | 2022 |
An injectable chitosan/dextran/β -glycerophosphate hydrogel as cell delivery carrier for therapy of myocardial infarction.
Topics: 3T3 Cells; Animals; Biocompatible Materials; Cell Differentiation; Cell Survival; Chitosan; Connexin | 2020 |
An Injectable Nanocomposite Hydrogel for Potential Application of Vascularization and Tissue Repair.
Topics: Animals; Chemokine CXCL12; Chick Embryo; Chitosan; Chorioallantoic Membrane; Coculture Techniques; E | 2020 |
Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart.
Topics: Alginates; Animals; Biocompatible Materials; Cell Survival; Cells, Cultured; Cells, Immobilized; Chi | 2014 |